Proton Pump Inhibitors: What the Internist Needs to Know

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This report reviews the physiology of gastric acid suppression by proton pump inhibitors (PPIs) and anti-inflammatory effects of PPIs that are independent of their acid-suppressive effects. Valid indications for PPI use are discussed, as are putative adverse effects of PPIs that have been identified through weak associations in observational studies that cannot establish cause-and-effect relationships. Although evidence supporting the validity of these adverse effects is weak, there is also insufficient evidence to dismiss the risks. The report emphasizes how PPIs frequently are prescribed inappropriately and encourages physicians to carefully consider the indication for PPI therapy in their patients.

Original languageEnglish (US)
JournalMedical Clinics of North America
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Proton Pump Inhibitors
Gastric Acid
Observational Studies
Anti-Inflammatory Agents
Physicians
Acids

Keywords

  • Complications
  • Gastroesophageal reflux disease
  • Peptic ulcer disease
  • Proton pump inhibitor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Proton Pump Inhibitors : What the Internist Needs to Know. / Spechler, Stuart J.

In: Medical Clinics of North America, 01.01.2018.

Research output: Contribution to journalArticle

@article{e6f045d73bce49ffa00d3d385b6c4bde,
title = "Proton Pump Inhibitors: What the Internist Needs to Know",
abstract = "This report reviews the physiology of gastric acid suppression by proton pump inhibitors (PPIs) and anti-inflammatory effects of PPIs that are independent of their acid-suppressive effects. Valid indications for PPI use are discussed, as are putative adverse effects of PPIs that have been identified through weak associations in observational studies that cannot establish cause-and-effect relationships. Although evidence supporting the validity of these adverse effects is weak, there is also insufficient evidence to dismiss the risks. The report emphasizes how PPIs frequently are prescribed inappropriately and encourages physicians to carefully consider the indication for PPI therapy in their patients.",
keywords = "Complications, Gastroesophageal reflux disease, Peptic ulcer disease, Proton pump inhibitor",
author = "Spechler, {Stuart J}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.mcna.2018.08.001",
language = "English (US)",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Proton Pump Inhibitors

T2 - What the Internist Needs to Know

AU - Spechler, Stuart J

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This report reviews the physiology of gastric acid suppression by proton pump inhibitors (PPIs) and anti-inflammatory effects of PPIs that are independent of their acid-suppressive effects. Valid indications for PPI use are discussed, as are putative adverse effects of PPIs that have been identified through weak associations in observational studies that cannot establish cause-and-effect relationships. Although evidence supporting the validity of these adverse effects is weak, there is also insufficient evidence to dismiss the risks. The report emphasizes how PPIs frequently are prescribed inappropriately and encourages physicians to carefully consider the indication for PPI therapy in their patients.

AB - This report reviews the physiology of gastric acid suppression by proton pump inhibitors (PPIs) and anti-inflammatory effects of PPIs that are independent of their acid-suppressive effects. Valid indications for PPI use are discussed, as are putative adverse effects of PPIs that have been identified through weak associations in observational studies that cannot establish cause-and-effect relationships. Although evidence supporting the validity of these adverse effects is weak, there is also insufficient evidence to dismiss the risks. The report emphasizes how PPIs frequently are prescribed inappropriately and encourages physicians to carefully consider the indication for PPI therapy in their patients.

KW - Complications

KW - Gastroesophageal reflux disease

KW - Peptic ulcer disease

KW - Proton pump inhibitor

UR - http://www.scopus.com/inward/record.url?scp=85055208862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055208862&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2018.08.001

DO - 10.1016/j.mcna.2018.08.001

M3 - Article

C2 - 30466666

AN - SCOPUS:85055208862

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

ER -